Boston Scientific Corp (BSX)vsPDD Holdings Inc. (PDD)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
PDD
PDD Holdings Inc.
$102.61
+4.61%
CONSUMER CYCLICAL · Cap: $139.25B
Smart Verdict
WallStSmart Research — data-driven comparison
PDD Holdings Inc. generates 1985% more annual revenue ($418.54B vs $20.07B). PDD leads profitability with a 24.4% profit margin vs 14.4%. BSX appears more attractively valued with a PEG of 0.75. PDD earns a higher WallStSmart Score of 77/100 (B+).
BSX
Buy63
out of 100
Grade: C+
PDD
Strong Buy77
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Margin of Safety
+67.8%
Fair Value
$332.33
Current Price
$102.61
$229.72 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Attractively priced relative to earnings
Every $100 of equity generates 31 in profit
Conservative balance sheet, low leverage
Generating 45.7B in free cash flow
Safe zone — low bankruptcy risk
Large-cap with strong market position
Areas to Watch
Premium valuation, high expectations priced in
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : PDD
The strongest argument for PDD centers on P/E Ratio, Return on Equity, Debt/Equity. Profitability is solid with margins at 24.4% and operating margin at 23.1%. PEG of 1.03 suggests the stock is reasonably priced for its growth.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : PDD
No major red flags identified for PDD, but monitor valuation.
Key Dynamics to Monitor
BSX profiles as a growth stock while PDD is a mature play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.70 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
PDD generates stronger free cash flow (45.7B), providing more financial flexibility.
Bottom Line
PDD scores higher overall (77/100 vs 63/100), backed by strong 24.4% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
PDD Holdings Inc.
CONSUMER CYCLICAL · INTERNET RETAIL · China
Pinduoduo Inc., operates an electronic commerce platform in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?